Rhonda Henry has joined Emmes’ BioPharma Group (Rockville, Md.) as president.
The Wilmington native has 30 years of clinical research experience, most recently as vice president of patient solutions at PPD.
In 2020, she was named to the PharmaVOICE 100 list of most inspiring people working in the life-sciences industry.
Before joining PPD, she spent eight years at New Hanover Regional Medical Center, starting as a phlebotomist and completing her tenure there as a nurse in medical/surgical and neurology areas.
According to Henry, “Two of the things that attracted me to Emmes were its excellent reputation and its 40-plus years in clinical research. The opportunity to work with Christine again, along with the conversations I had with members of Emmes’ leadership team, had a big impact on my decision.
MedCity News
Thermo Fisher’s $21B deal for PPD gives it missing piece in drug development cycle
Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services.
Shares0
Thermo Fisher Scientific sells the laboratory equipment that biopharmaceutical companies use in the research and development of new drugs. Its $20.9 billion acquisition of PPD will give the company the global infrastructure to run the clinical trials that test them.
Waltham, Massachusetts-based Thermo Fisher announced Thursday that it has agreed to pay $17.4 billion cash for PPD, breaking down to $47.50 for each share of the company. That price represents a premium of about 24% to PPD’s closing stock price on Tuesday, before news surfaced about a potential deal. Shares of PPD, a pharmaceutical
PPD sold to Thermo Fisher Scientific What it means for Wilmington starnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from starnewsonline.com Daily Mail and Mail on Sunday newspapers.
Coronavirus Litigation: The Week In Review By Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing.
Sign up for our Appellate newsletter
You must correct or enter the following before you can sign up:
Email (NOTE: Free email domains not supported)
Primary area of interest
Thank You! Law360 (February 18, 2021, 7:32 PM EST)